Search

everythinglearnresearchcommunity

for

Search:↓

Maidenhair fern might help with COVID-19 symptoms, but it needs more testing.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

A man developed an allergic skin reaction after using brimonidine for rosacea.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

COVID-19 can cause various skin issues, from mild rashes to severe conditions.

The AndroCoV Clinical Scoring is an accurate, easy, and free way to diagnose COVID-19 without a lab test.

The skin conditions of Iraqi women changed during the COVID-19 pandemic, with more hair loss and skin irritation but fewer contagious skin infections.

Live vaccines can be safely given to infants with a FOXN1 variant if their immune function improves over time.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

COVID-19 may trigger sudden temporary hair loss.

A specific gene mutation causes vitamin D-resistant rickets and hair loss.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Long COVID causes various long-term health issues and needs better awareness and treatment.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Two existing drugs may help treat COVID-19 by inhibiting a key viral protein.

Genetic marker rs12558842 strongly linked to male hair loss.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

Most children recovered from COVID-19 in 4 weeks, but some experienced long-term symptoms, especially older kids.

A new mutation in the mitochondrial DNA was found in a boy with MELAS, even though his family didn't show typical signs.

Early diagnosis and multidisciplinary care are crucial for improving the quality of life in patients with ectodermal dysplasia.

COVID-19 can cause different types of hair loss, which may last up to 100 days, and treatments are still being explored.

A genetic variant in "Blonde d'Aquitaine" calves causes death at birth due to a missing protein.

Patients with a specific genetic variant have more severe alopecia areata and higher recurrence rates.

A patient developed a severe skin reaction and died after taking hydroxychloroquine for COVID-19.

AIRE protein, defective in APECED patients, is found in skin and hair cells and interacts with cytokeratin 17.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

Foals with Rhodococcus equi infection often have other health problems that lower their chances of survival.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.